Search results
Results from the WOW.Com Content Network
A 23andMe spokesperson told Business Insider that Wojcicki still intends to take the company private. 23andMe agreed to a $30 million settlement in a class-action lawsuit 23andMe agreed to settle ...
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
As recently as 2022, Wojcicki told MBA students at Stanford’s Graduate School of Business that 23andMe was still finding its product-market fit, meaning that its tests had not yet become tools ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers' DNA and other data. On Tuesday, 23andMe released its latest earnings ...
All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan to take the company private. The departures leave just one sitting ...
23andMe, which went public in 2021, has struggled to find a profitable business model since. The company reported a net loss of $667 million for its last fiscal year, more than double the loss of ...
One thing to note is that 23andMe reports “do not diagnose any health conditions or provide medical advice,” according to the brand’s website. Total Health is a new foray for 23andme, but ...